Rubella Seroprevalence and real-time PCR detection of RUBV among Congolese pregnant women

Abstract Background Rubella is an acute infectious disease caused by Rubella virus (RUBV). RUBV remains an important pathogen worldwide, causing approximately 100 000 cases of congenital rubella syndrome (CRS) every year; and the most severe consequence of rubella is teratogenicity. The aim of this...

Full description

Bibliographic Details
Main Authors: Josue Zanga, Makola Kennedy Mbanzulu, Arnold-Freddy Kabasele, Nlandu Roger Ngatu, Dimosi Roger Wumba
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-017-2352-6
_version_ 1819063828576468992
author Josue Zanga
Makola Kennedy Mbanzulu
Arnold-Freddy Kabasele
Nlandu Roger Ngatu
Dimosi Roger Wumba
author_facet Josue Zanga
Makola Kennedy Mbanzulu
Arnold-Freddy Kabasele
Nlandu Roger Ngatu
Dimosi Roger Wumba
author_sort Josue Zanga
collection DOAJ
description Abstract Background Rubella is an acute infectious disease caused by Rubella virus (RUBV). RUBV remains an important pathogen worldwide, causing approximately 100 000 cases of congenital rubella syndrome (CRS) every year; and the most severe consequence of rubella is teratogenicity. The aim of this study was to estimate the prevalence of RUBV IgG antibodies and determine RUBV genotypes in Congolese pregnant women in Kongo central province, Democratic Republic of Congo (DRC). Methods This was a prospective cross-sectional study that consisted of a laboratory analysis of blood samples from 78 pregnant women to check for the presence of RUBV IgG antibodies, and also determine RUBV genotypes in seropositive samples (using primers targeting RUBV nucleoprotein), with the use of serological and molecular methods, respectively. Participants were pregnant women attending antenatal care clinics (ANC) at two health zones of Kisantu town in DRC. They were followed-up from the first to third trimester. Those who were negative for RUBV antibodies at the initial assay (first trimester) were tested in the second and, eventually, the third trimester. Results An overall rubella seroprevalence of 58.97% was observed, whereas RUBV nucleoprotein was detected in 60% of randomly selected 30 blood samples among the 46 RUBV seropositive pregnant women. Five (27.77%) of positive samples were positive for both RUBV genotypes (RV8633/9112 and RV8945/9577), whereas 11 (61.11%) of them were positive for RV8633/9112 and two (11.11%) were positive for RV8945/9577 only. Regarding rubella clinical signs and complications, two subjects (2.56%) presented with fever, whereas five pregnant women (6.41%) had experienced abortion. None (0%) of the participants has been vaccinated against RUBV. Conclusions Findings from this study suggest that RUBV is prevalent in Congolese pregnant women. Further research is required to elucidate the molecular epidemiology of RUBV in order to design a rational rubella surveillance and control program in DRC.
first_indexed 2024-12-21T15:20:53Z
format Article
id doaj.art-5d83291355914c5d8024cdee7ed30b2e
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-21T15:20:53Z
publishDate 2017-04-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-5d83291355914c5d8024cdee7ed30b2e2022-12-21T18:59:02ZengBMCBMC Infectious Diseases1471-23342017-04-011711710.1186/s12879-017-2352-6Rubella Seroprevalence and real-time PCR detection of RUBV among Congolese pregnant womenJosue Zanga0Makola Kennedy Mbanzulu1Arnold-Freddy Kabasele2Nlandu Roger Ngatu3Dimosi Roger Wumba4Department of Tropical Medicine, Faculty of Medicine, University of KinshasaDepartment of Tropical Medicine, Faculty of Medicine, University of KinshasaDepartment of Tropical Medicine, Faculty of Medicine, University of KinshasaGraduate School of Health Sciences & Nursing, University of KochiDepartment of Tropical Medicine, Faculty of Medicine, University of KinshasaAbstract Background Rubella is an acute infectious disease caused by Rubella virus (RUBV). RUBV remains an important pathogen worldwide, causing approximately 100 000 cases of congenital rubella syndrome (CRS) every year; and the most severe consequence of rubella is teratogenicity. The aim of this study was to estimate the prevalence of RUBV IgG antibodies and determine RUBV genotypes in Congolese pregnant women in Kongo central province, Democratic Republic of Congo (DRC). Methods This was a prospective cross-sectional study that consisted of a laboratory analysis of blood samples from 78 pregnant women to check for the presence of RUBV IgG antibodies, and also determine RUBV genotypes in seropositive samples (using primers targeting RUBV nucleoprotein), with the use of serological and molecular methods, respectively. Participants were pregnant women attending antenatal care clinics (ANC) at two health zones of Kisantu town in DRC. They were followed-up from the first to third trimester. Those who were negative for RUBV antibodies at the initial assay (first trimester) were tested in the second and, eventually, the third trimester. Results An overall rubella seroprevalence of 58.97% was observed, whereas RUBV nucleoprotein was detected in 60% of randomly selected 30 blood samples among the 46 RUBV seropositive pregnant women. Five (27.77%) of positive samples were positive for both RUBV genotypes (RV8633/9112 and RV8945/9577), whereas 11 (61.11%) of them were positive for RV8633/9112 and two (11.11%) were positive for RV8945/9577 only. Regarding rubella clinical signs and complications, two subjects (2.56%) presented with fever, whereas five pregnant women (6.41%) had experienced abortion. None (0%) of the participants has been vaccinated against RUBV. Conclusions Findings from this study suggest that RUBV is prevalent in Congolese pregnant women. Further research is required to elucidate the molecular epidemiology of RUBV in order to design a rational rubella surveillance and control program in DRC.http://link.springer.com/article/10.1186/s12879-017-2352-6Democratic Republic of CongoKisantu townReal-time PCRRubella virus infectionSeroprevalence
spellingShingle Josue Zanga
Makola Kennedy Mbanzulu
Arnold-Freddy Kabasele
Nlandu Roger Ngatu
Dimosi Roger Wumba
Rubella Seroprevalence and real-time PCR detection of RUBV among Congolese pregnant women
BMC Infectious Diseases
Democratic Republic of Congo
Kisantu town
Real-time PCR
Rubella virus infection
Seroprevalence
title Rubella Seroprevalence and real-time PCR detection of RUBV among Congolese pregnant women
title_full Rubella Seroprevalence and real-time PCR detection of RUBV among Congolese pregnant women
title_fullStr Rubella Seroprevalence and real-time PCR detection of RUBV among Congolese pregnant women
title_full_unstemmed Rubella Seroprevalence and real-time PCR detection of RUBV among Congolese pregnant women
title_short Rubella Seroprevalence and real-time PCR detection of RUBV among Congolese pregnant women
title_sort rubella seroprevalence and real time pcr detection of rubv among congolese pregnant women
topic Democratic Republic of Congo
Kisantu town
Real-time PCR
Rubella virus infection
Seroprevalence
url http://link.springer.com/article/10.1186/s12879-017-2352-6
work_keys_str_mv AT josuezanga rubellaseroprevalenceandrealtimepcrdetectionofrubvamongcongolesepregnantwomen
AT makolakennedymbanzulu rubellaseroprevalenceandrealtimepcrdetectionofrubvamongcongolesepregnantwomen
AT arnoldfreddykabasele rubellaseroprevalenceandrealtimepcrdetectionofrubvamongcongolesepregnantwomen
AT nlandurogerngatu rubellaseroprevalenceandrealtimepcrdetectionofrubvamongcongolesepregnantwomen
AT dimosirogerwumba rubellaseroprevalenceandrealtimepcrdetectionofrubvamongcongolesepregnantwomen